Related Experiment Video
Updated: May 29, 2026
Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
[Target-specific screening of antivirulence preparations for chronic infection therapy]
Abstract:
Global spread of clinically significant strains resistant to antibiotics necessitated the development of new approaches to generation of antibacterial preparations. Selection of virulence factors as targets for new preparations is an alternative approach to therapy of infections caused by resistant strains and chronic infectious diseases. Contemporary state of research aimed at target selection among virulence factors of pathogenic for humans bacteria that cause chronic infections, and screening of specific inhibitors of these targets are examined. Analysis of limited data of therapeutic activity of selected preparations, i.e. experimental confirmation of the proposed concept, is provided.
Insights
New antibacterial strategies are needed due to rising antibiotic resistance. Targeting bacterial virulence factors offers a promising alternative for treating resistant and chronic infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Discovery
Context:
- Increasing global antibiotic resistance necessitates novel therapeutic strategies.
- Traditional antibiotics are becoming less effective against resistant bacterial strains.
- Chronic infections pose significant treatment challenges.
Purpose:
- To review current research on identifying virulence factors as targets for new antibacterial agents.
- To examine the screening process for inhibitors targeting these virulence factors.
- To assess the therapeutic potential of novel antibacterial preparations targeting virulence.
Summary:
- This review focuses on selecting bacterial virulence factors as targets for new antibacterial drug development.
- It explores contemporary research in identifying and screening inhibitors for these targets in human pathogens causing chronic infections.
- Limited data on the therapeutic efficacy of developed agents is analyzed to validate the concept.
Impact:
- Provides a comprehensive overview of virulence factor-targeted antibacterial drug discovery.
- Highlights a promising alternative approach to combatting antibiotic-resistant bacteria.
- Informs future research and development of novel treatments for infectious diseases.
